Skip to main content
KMDA
NASDAQ Life Sciences

Director David Tsur Sells $1.46M of Kamada Shares

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$7.945
Mkt Cap
$458.381M
52W Low
$6.5
52W High
$9.35
52W Position info
22% above low
Off High info
15% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

KMDA sits 22% above its 52-week low of $6.5.

Summary

Kamada director David Tsur sold $1.46 million worth of shares over three days in early September 2026, reducing his stake to 593,691 shares.


Key Events · Ownership and Investor Activity · KMDA

  • Director Sells $1.46M in Open Market

    David Tsur disposed of 177,173 ordinary shares for $1,463,734 across three transactions on September 7-9, 2026, at prices between $8.26 and $8.28 per share.

  • Post-Sale Holdings Reduced

    Following the sales, Tsur's direct holdings stand at 593,691 shares, down from 770,864 shares before the transactions.

  • Sale Follows Strong Results and Dividend

    The sale comes after record H1 2026 results reported on August 12 and a $0.17 per share dividend declared on August 17, payable September 17, 2026.


Analysis · KMDA · Life Sciences

A board member's sale of this magnitude warrants attention, even though directors are not operational executives. David Tsur sold 177,173 ordinary shares for approximately $1.46 million across three transactions on September 7-9, 2026, at prices between $8.26 and $8.28 per share. The sale represents about 0.32% of the company's market capitalization and reduces his direct holdings to 593,691 shares. Notably, it follows a period of strong financial results and a recent dividend declaration.

How filings like this one have moved

In the 30 days to Sep 11, 2026, 30.5% of the 1973 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.21%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, KMDA was trading at $7.95 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $458.4M. The 52-week trading range was $6.50 to $9.35. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

KMDA - Latest Insights

KMDA
Aug 12, 2026, 7:29 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $7.20
Real-time Price: $7.95 info
Change: +$0.745 (+10%) info
Market Cap: $458.381M info
KMDA
Aug 12, 2026, 7:14 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $7.20
Real-time Price: $7.95 info
Change: +$0.745 (+10%) info
Market Cap: $458.381M info
KMDA
Aug 12, 2026, 7:05 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $7.20
Real-time Price: $7.95 info
Change: +$0.745 (+10%) info
Market Cap: $458.381M info
KMDA
Jul 20, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $6.91
Real-time Price: $7.95 info
Change: +$1.04 (+15%) info
Market Cap: $458.381M info
KMDA
Jul 20, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $7.43
Real-time Price: $7.95 info
Change: +$0.515 (+7%) info
Market Cap: $458.381M info